270 related articles for article (PubMed ID: 28377036)
21. Optical Coherence Tomography Angiography Characteristics of Iris Melanocytic Tumors.
Skalet AH; Li Y; Lu CD; Jia Y; Lee B; Husvogt L; Maier A; Fujimoto JG; Thomas CR; Huang D
Ophthalmology; 2017 Feb; 124(2):197-204. PubMed ID: 27856029
[TBL] [Abstract][Full Text] [Related]
22. Palladium 103 plaque radiotherapy for uveal melanoma. Clinical experience.
Finger PT; Buffa A; Mishra S; Berson A; Bosworth JL; Vikram B
Ophthalmology; 1994 Feb; 101(2):256-63. PubMed ID: 8115147
[TBL] [Abstract][Full Text] [Related]
23. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
24. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
[TBL] [Abstract][Full Text] [Related]
25. Plaque radiotherapy for choroidal melanoma encircling the optic disc (circumpapillary choroidal melanoma).
Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
Arch Ophthalmol; 2007 Sep; 125(9):1202-9. PubMed ID: 17846359
[TBL] [Abstract][Full Text] [Related]
26. Management of iris melanomas with 125Iodine plaque radiotherapy.
Fernandes BF; Krema H; Fulda E; Pavlin CJ; Payne DG; McGowan HD; Simpson ER
Am J Ophthalmol; 2010 Jan; 149(1):70-6. PubMed ID: 19892312
[TBL] [Abstract][Full Text] [Related]
27. Extraocular muscle repositioning and diplopia: associated with ophthalmic plaque radiation therapy for choroidal melanoma.
Nagendran ST; Finger PT; Campolattaro BN
Ophthalmology; 2014 Nov; 121(11):2268-74. PubMed ID: 25062940
[TBL] [Abstract][Full Text] [Related]
28. Subfoveal choroidal melanoma: pretreatment characteristics and response to plaque radiation therapy.
Newman H; Chin KJ; Finger PT
Arch Ophthalmol; 2011 Jul; 129(7):892-8. PubMed ID: 21746980
[TBL] [Abstract][Full Text] [Related]
29. Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.
Shields CL; Sioufi K; Srinivasan A; Di Nicola M; Masoomian B; Barna LE; Bekerman VP; Say EAT; Mashayekhi A; Emrich J; Komarnicky L; Shields JA
JAMA Ophthalmol; 2018 Dec; 136(12):1325-1333. PubMed ID: 30267070
[TBL] [Abstract][Full Text] [Related]
30. Palladium 103 (103Pd) plaque radiation therapy for circumscribed choroidal hemangioma with retinal detachment.
Aizman A; Finger PT; Shabto U; Szechter A; Berson A
Arch Ophthalmol; 2004 Nov; 122(11):1652-6. PubMed ID: 15534126
[TBL] [Abstract][Full Text] [Related]
31. Plaque radiotherapy treatment with ruthenium-106 for iris malignant melanoma.
Tsimpida M; Hungerford J; Arora A; Cohen V
Eye (Lond); 2011 Dec; 25(12):1607-11. PubMed ID: 21941358
[TBL] [Abstract][Full Text] [Related]
32. Modified COMS plaques for 125I and 103Pd iris melanoma brachytherapy.
Thomson RM; Furutani KM; Pulido JS; Stafford SL; Rogers DW
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1261-9. PubMed ID: 20472360
[TBL] [Abstract][Full Text] [Related]
33. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
Finger PT; Chin KJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
[TBL] [Abstract][Full Text] [Related]
34. Treatment of non-resectable malignant iris tumours with custom designed plaque radiotherapy.
Shields CL; Shields JA; De Potter P; Singh AD; Hernandez C; Brady LW
Br J Ophthalmol; 1995 Apr; 79(4):306-12. PubMed ID: 7742272
[TBL] [Abstract][Full Text] [Related]
35. Palladium-103 plaque radiotherapy for choroidal melanoma: an 11-year study.
Finger PT; Berson A; Ng T; Szechter A
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1438-45. PubMed ID: 12459367
[TBL] [Abstract][Full Text] [Related]
36. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
[TBL] [Abstract][Full Text] [Related]
37. Proton Beam Therapy for Iris Melanomas in 107 Patients.
Thariat J; Rahmi A; Salleron J; Mosci C; Butet B; Maschi C; Lanza F; Lanteri S; Baillif S; Herault J; Mathis T; Caujolle JP
Ophthalmology; 2018 Apr; 125(4):606-614. PubMed ID: 29128229
[TBL] [Abstract][Full Text] [Related]
38. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization.
Finger PT; Berson A; Ng T; Szechter A
Am J Ophthalmol; 1999 Feb; 127(2):170-7. PubMed ID: 10030559
[TBL] [Abstract][Full Text] [Related]
39. Conservative management of suspicious melanocytic lesions of the iris.
Oxenreiter MM; Lane AM; Jain P; Kim IK; Gragoudas ES
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1319-1324. PubMed ID: 30919077
[TBL] [Abstract][Full Text] [Related]
40. Changes in ultrasound findings in posterior uveal melanoma after Ruthenium 106 brachytherapy.
Kaiserman I; Anteby I; Chowers I; Blumenthal EZ; Kliers I; Pe'er J
Ophthalmology; 2002 Jun; 109(6):1137-41. PubMed ID: 12045056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
